# Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography

> **NCT01848899** · PHASE4 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 100 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Iodixanol
- **DRUG:** Ioxaglate
- **DRUG:** Bivalirudin

## Key facts

- **NCT ID:** NCT01848899
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2013-11
- **Final completion:** 2014-11
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01848899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01848899, "Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01848899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*